Bincy Augustine, PharmD MBA, has a diverse work experience in the pharmaceutical industry. Bincy currently works at Daiichi Sankyo, Inc., where they hold the position of Associate Director, Global Oncology Marketing ENHERTU. Prior to this role, they served as the Global Oncology Marketing Rotation for ENHERTU and also as the Associate Director for Global Oncology R&D. In these roles, Bincy was responsible for managing scientific strategies, implementing strategic initiatives, managing external collaborations, and reporting key insights to senior leadership.
Before joining Daiichi Sankyo, Bincy worked at Actelion as a Clinical Development Fellow. In this role, they assisted in the development and validation of clinical trial-related documents, supported science in strategic meetings, managed vendors, and participated in recruitment initiatives.
Bincy also completed a Postdoctoral Fellowship at Rutgers Pharmaceutical Industry Fellowship (RPIF) Program, where they gained valuable experience in the pharmaceutical industry.
In addition, Bincy has worked as an APPE Pharmacy Extern at Express Scripts, where they gained experience in pharmacy benefit management, and as a Pharmacy Intern at Walgreens, specializing in HIV care. Bincy provided consultations, managed prescription orders and reimbursements, and performed health screenings with excellent customer service.
Bincy's experience also includes working as a Research Assistant at St. Louis College of Pharmacy.
With their extensive experience in various roles in the pharmaceutical industry, Bincy Augustine brings a wealth of knowledge and expertise to their current position.
Bincy Augustine completed their Doctor of Pharmacy (Pharm.D.) degree from the University of Health Sciences and Pharmacy in St. Louis, from 2011 to 2017. Subsequently, they pursued a Master of Business Administration (MBA) degree from Rutgers Business School, between 2018 and 2020. In addition, they obtained certifications in IRB-Human Biomedical Research from CITI Program, a Registered Pharmacist designation from the New Jersey Division of Consumer Affairs - Board of Pharmacy, and ICH-GCP from Whitehall Training in August 2017.
Sign up to view 0 direct reports
Get started